These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
296 related articles for article (PubMed ID: 31898880)
1. Multicenter Ozone Study in oldEr Subjects (MOSES): Part 1. Effects of Exposure to Low Concentrations of Ozone on Respiratory and Cardiovascular Outcomes. Frampton MW; Balmes JR; Bromberg PA; Stark P; Arjomandi M; Hazucha MJ; Rich DQ; Hollenbeck-Pringle D; Dagincourt N; Alexis N; Ganz P; Zareba W; Costantini MG Res Rep Health Eff Inst; 2017 Jun; 2017(192, Pt 1):1-107. PubMed ID: 31898880 [TBL] [Abstract][Full Text] [Related]
2. Multicenter Ozone Study in oldEr Subjects (MOSES): Part 2. Effects of Personal and Ambient Concentrations of Ozone and Other Pollutants on Cardiovascular and Pulmonary Function. Rich DQ; Frampton MW; Balmes JR; Bromberg PA; Arjomandi M; Hazucha MJ; Thurston SW; Alexis NE; Ganz P; Zareba W; Koutrakis P; Thevenet-Morrison K Res Rep Health Eff Inst; 2020 Mar; 2020(192, Pt 2):1-90. PubMed ID: 32239870 [TBL] [Abstract][Full Text] [Related]
3. Do Ambient Ozone or Other Pollutants Modify Effects of Controlled Ozone Exposure on Pulmonary Function? Rich DQ; Thurston SW; Balmes JR; Bromberg PA; Arjomandi M; Hazucha MJ; Alexis NE; Ganz P; Zareba W; Thevenet-Morrison K; Koutrakis P; Frampton MW Ann Am Thorac Soc; 2020 May; 17(5):563-572. PubMed ID: 32125874 [No Abstract] [Full Text] [Related]
4. Ozone effects on blood biomarkers of systemic inflammation, oxidative stress, endothelial function, and thrombosis: The Multicenter Ozone Study in oldEr Subjects (MOSES). Balmes JR; Arjomandi M; Bromberg PA; Costantini MG; Dagincourt N; Hazucha MJ; Hollenbeck-Pringle D; Rich DQ; Stark P; Frampton MW PLoS One; 2019; 14(9):e0222601. PubMed ID: 31553765 [TBL] [Abstract][Full Text] [Related]
5. Mortality and Morbidity Effects of Long-Term Exposure to Low-Level PM Brunekreef B; Strak M; Chen J; Andersen ZJ; Atkinson R; Bauwelinck M; Bellander T; Boutron MC; Brandt J; Carey I; Cesaroni G; Forastiere F; Fecht D; Gulliver J; Hertel O; Hoffmann B; de Hoogh K; Houthuijs D; Hvidtfeldt U; Janssen N; Jorgensen J; Katsouyanni K; Ketzel M; Klompmaker J; Hjertager Krog N; Liu S; Ljungman P; Mehta A; Nagel G; Oftedal B; Pershagen G; Peters A; Raaschou-Nielsen O; Renzi M; Rodopoulou S; Samoli E; Schwarze P; Sigsgaard T; Stafoggia M; Vienneau D; Weinmayr G; Wolf K; Hoek G Res Rep Health Eff Inst; 2021 Sep; 2021(208):1-127. PubMed ID: 36106702 [TBL] [Abstract][Full Text] [Related]
6. Cardiorespiratory biomarker responses in healthy young adults to drastic air quality changes surrounding the 2008 Beijing Olympics. Zhang J; Zhu T; Kipen H; Wang G; Huang W; Rich D; Zhu P; Wang Y; Lu SE; Ohman-Strickland P; Diehl S; Hu M; Tong J; Gong J; Thomas D; Res Rep Health Eff Inst; 2013 Feb; (174):5-174. PubMed ID: 23646463 [TBL] [Abstract][Full Text] [Related]
7. Respiratory Responses to Ozone Exposure. MOSES (The Multicenter Ozone Study in Older Subjects). Arjomandi M; Balmes JR; Frampton MW; Bromberg P; Rich DQ; Stark P; Alexis NE; Costantini M; Hollenbeck-Pringle D; Dagincourt N; Hazucha MJ Am J Respir Crit Care Med; 2018 May; 197(10):1319-1327. PubMed ID: 29232153 [TBL] [Abstract][Full Text] [Related]
8. Ambient and Controlled Particle Exposures as Triggers for Acute ECG Changes. Rich DQ; Peters A; Schneider A; Zareba W; Breitner S; Oakes D; Wiltshire J; Kane C; Frampton MW; Hampel R; Hopke PK; Cyrys J; Utell MJ Res Rep Health Eff Inst; 2016 May; (186):5-75. PubMed ID: 28661614 [TBL] [Abstract][Full Text] [Related]
9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
10. Cardiovascular function and ozone exposure: The Multicenter Ozone Study in oldEr Subjects (MOSES). Rich DQ; Balmes JR; Frampton MW; Zareba W; Stark P; Arjomandi M; Hazucha MJ; Costantini MG; Ganz P; Hollenbeck-Pringle D; Dagincourt N; Bromberg PA Environ Int; 2018 Oct; 119():193-202. PubMed ID: 29980042 [TBL] [Abstract][Full Text] [Related]
11. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial. Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543 [TBL] [Abstract][Full Text] [Related]
12. Effects of exposure to ultrafine carbon particles in healthy subjects and subjects with asthma. Frampton MW; Utell MJ; Zareba W; Oberdörster G; Cox C; Huang LS; Morrow PE; Lee FE; Chalupa D; Frasier LM; Speers DM; Stewart J Res Rep Health Eff Inst; 2004 Dec; (126):1-47; discussion 49-63. PubMed ID: 15768531 [TBL] [Abstract][Full Text] [Related]
13. Cardiovascular effects of ozone in healthy subjects with and without deletion of glutathione-S-transferase M1. Frampton MW; Pietropaoli A; Dentler M; Chalupa D; Little EL; Stewart J; Frasier L; Oakes D; Wiltshire J; Vora R; Utell MJ Inhal Toxicol; 2015 Feb; 27(2):113-9. PubMed ID: 25600221 [TBL] [Abstract][Full Text] [Related]
14. Effects of ozone on normal and potentially sensitive human subjects. Part II: Airway inflammation and responsiveness to ozone in nonsmokers and smokers. Frampton MW; Morrow PE; Torres A; Voter KZ; Whitin JC; Cox C; Speers DM; Tsai Y; Utell MJ Res Rep Health Eff Inst; 1997 Jun; (78):39-72; discussion 81-99. PubMed ID: 9387196 [TBL] [Abstract][Full Text] [Related]
15. Multicity study of air pollution and mortality in Latin America (the ESCALA study). Romieu I; Gouveia N; Cifuentes LA; de Leon AP; Junger W; Vera J; Strappa V; Hurtado-Díaz M; Miranda-Soberanis V; Rojas-Bracho L; Carbajal-Arroyo L; Tzintzun-Cervantes G; Res Rep Health Eff Inst; 2012 Oct; (171):5-86. PubMed ID: 23311234 [TBL] [Abstract][Full Text] [Related]
16. Lung function and inflammatory responses in healthy young adults exposed to 0.06 ppm ozone for 6.6 hours. Kim CS; Alexis NE; Rappold AG; Kehrl H; Hazucha MJ; Lay JC; Schmitt MT; Case M; Devlin RB; Peden DB; Diaz-Sanchez D Am J Respir Crit Care Med; 2011 May; 183(9):1215-21. PubMed ID: 21216881 [TBL] [Abstract][Full Text] [Related]
17. Mortality-Air Pollution Associations in Low Exposure Environments (MAPLE): Phase 2. Brauer M; Brook JR; Christidis T; Chu Y; Crouse DL; Erickson A; Hystad P; Li C; Martin RV; Meng J; Pappin AJ; Pinault LL; Tjepkema M; van Donkelaar A; Weagle C; Weichenthal S; Burnett RT Res Rep Health Eff Inst; 2022 Jul; 2022(212):1-91. PubMed ID: 36224709 [TBL] [Abstract][Full Text] [Related]
18. Lung Function and Short-Term Ambient Air Pollution Exposure: Differential Impacts of Omega-3 and Omega-6 Fatty Acids. Tong H; Zhang S; Shen W; Chen H; Salazar C; Schneider A; Rappold AG; Diaz-Sanchez D; Devlin RB; Samet JM Ann Am Thorac Soc; 2022 Apr; 19(4):583-593. PubMed ID: 34797737 [No Abstract] [Full Text] [Related]
19. The Effects of Policy-Driven Air Quality Improvements on Children's Respiratory Health. Gilliland F; Avol E; McConnell R; Berhane K; Gauderman WJ; Lurmann FW; Urman R; Chang R; Rappaport EB; Howland S Res Rep Health Eff Inst; 2017 Jan; 2017(190):1-75. PubMed ID: 31898879 [TBL] [Abstract][Full Text] [Related]
20. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial. Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]